Rothschild & Co. Asset Management US Inc. lessened its stake in shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) by 29.9% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 373,568 shares of the company’s stock after selling 158,964 shares during the quarter. Rothschild & Co. Asset Management US Inc.’s holdings in Acadia Healthcare were worth $13,056,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Private Capital Group LLC grew its holdings in Acadia Healthcare by 67.3% during the 1st quarter. Private Capital Group LLC now owns 865 shares of the company’s stock valued at $25,000 after buying an additional 348 shares in the last quarter. Twin Tree Management LP grew its holdings in Acadia Healthcare by 3,472.3% during the 1st quarter. Twin Tree Management LP now owns 2,965 shares of the company’s stock valued at $87,000 after buying an additional 2,882 shares in the last quarter. Advisor Group Inc. grew its holdings in Acadia Healthcare by 23.9% during the 4th quarter. Advisor Group Inc. now owns 3,039 shares of the company’s stock valued at $78,000 after buying an additional 587 shares in the last quarter. Quantamental Technologies LLC purchased a new position in Acadia Healthcare during the 1st quarter valued at about $94,000. Finally, BNP Paribas Arbitrage SA grew its holdings in Acadia Healthcare by 228.7% during the 1st quarter. BNP Paribas Arbitrage SA now owns 4,806 shares of the company’s stock valued at $141,000 after buying an additional 3,344 shares in the last quarter.
A number of research firms have weighed in on ACHC. ValuEngine raised Acadia Healthcare from a “strong sell” rating to a “sell” rating in a report on Wednesday, April 24th. Deutsche Bank set a $32.00 price objective on Acadia Healthcare and gave the stock a “hold” rating in a report on Thursday, May 2nd. BMO Capital Markets boosted their price objective on Acadia Healthcare from $33.00 to $36.00 and gave the stock a “market perform” rating in a report on Wednesday, May 1st. BidaskClub lowered Acadia Healthcare from a “sell” rating to a “strong sell” rating in a report on Tuesday. Finally, Mizuho set a $30.00 price objective on Acadia Healthcare and gave the stock a “hold” rating in a report on Friday, May 31st. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $36.90.
Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Tuesday, July 30th. The company reported $0.61 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.59 by $0.02. The company had revenue of $789.00 million during the quarter, compared to the consensus estimate of $795.31 million. Acadia Healthcare had a positive return on equity of 7.20% and a negative net margin of 6.80%. Acadia Healthcare’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.70 EPS. On average, equities research analysts forecast that Acadia Healthcare Company Inc will post 2.15 earnings per share for the current year.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.
Recommended Story: Investing strategies using the yield curve
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company Inc (NASDAQ:ACHC).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.